Billerica, MA – Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the issuance of a new patent (US 12,222,279 B2) for its advanced flow-cell technology, reinforcing the company’s commitment to driving innovation in bioprocess analytics. This milestone expands Nirrin’s capabilities in real-time process monitoring, offering greater precision, flexibility, and efficiency [...]

BOSTON -- Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, today announced a comprehensive collaboration with Cell Signaling Technology (CST), a global leader in high-quality research antibodies and associated reagents. This collaboration will explore Leveragen’s proprietary Singularity Musculus platform to expedite the development of mouse-derived nanobodies tailored for reagent antibody [...]

Christian Uhrich, Investment Director at M Ventures, joins Vizgen Board of Directors; Chad Brown joins the company as Chief Commercial Officer CAMBRIDGE, Mass. -- Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced two key appointments aimed at advancing the company’s future strategy and execution. Christian Uhrich, [...]

Investment from Audax Strategic Capital aims to help extend growth runway and accelerate M&A. NEW YORK & PITTSBURGH -- Audax Strategic Capital ("ASC" or "Audax"), a provider of customized, mid-hold equity solutions, announced today an investment in TCP Analytical, a portfolio company of Riverarch Equity Partners ("Riverarch") and an established manufacturer and distributor of specialty [...]

SAN JOSE, Calif. – Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a commercial partnership with Human Cell Atlas (HCA) to offer its STOmics spatial transcriptomics products to HCA members. Human Cell Atlas (HCA), an international collaborative research consortium, is mapping all cell types in the [...]

Stephen MacMillan to retire from the Board SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb, MD, has been elected non-executive Chair of Illumina's Board. Dr. Gottlieb has served on the Board of Directors since 2020. Additionally, Keith Meister, [...]

The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). Dan brings a wealth of experience from the life science and healthcare industries, having held leadership roles at e.g. QleanAir, Carmel Pharma and Mölnlycke. Most recently, he served as CEO of Coala [...]

Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif. -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of the NULISAseq Mouse Panel 120, an innovative biomarker profiling solution that provides the most comprehensive coverage [...]

AlidaBio EpiPlex™ customers now have cloud access to the EpiScout™ analysis software on DNAnexus’ secure, scalable precision health data cloud platform MOUNTAIN VIEW, Calif. -- DNAnexus, provider of the leading enterprise platform for precision health data, and Alida Biosciences (AlidaBio), a leader in RNA epigenomic research tools, today announced a strategic collaboration designed to accelerate discovery and [...]

Innovative technology supports testing of accuracy and reliability in Autolus Therapeutics’ recently approved CAR T therapy AUCATZYL® SANTA CLARA, Calif. --  Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL® , a recently approved CAR T therapy. Agilent's advanced cell analysis instrumentation, specifically the xCELLigence Real-Time Cell Analysis (RTCA) technology, [...]